- Investing Ideas
- Japanese Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Japanese Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Results
10
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
10 companies
Chugai Pharmaceutical
Market Cap: JP¥12.1t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,325.00
7D
-0.9%
1Y
4.6%
Otsuka Holdings
Market Cap: JP¥5.8t
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
4578
JP¥11,000.00
7D
-1.7%
1Y
67.1%
Daiichi Sankyo Company
Market Cap: JP¥5.0t
Manufactures and sells pharmaceutical products in Japan and internationally.
4568
JP¥2,791.00
7D
2.2%
1Y
-22.4%
Astellas Pharma
Market Cap: JP¥3.9t
Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.
4503
JP¥2,151.00
7D
0.4%
1Y
48.5%
Kyowa Kirin
Market Cap: JP¥1.4t
Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.
4151
JP¥2,654.50
7D
0.5%
1Y
5.2%
Eisai
Market Cap: JP¥1.3t
Engages in the research, development, manufacture, and sale of pharmaceuticals in Japan.
4523
JP¥4,450.00
7D
3.6%
1Y
12.7%
Ono Pharmaceutical
Market Cap: JP¥1.1t
Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.
4528
JP¥2,425.50
7D
-0.1%
1Y
51.6%
Pharma Foods International
Market Cap: JP¥17.1b
Engages in the development and sale of functional food ingredients in Japan.
2929
JP¥588.00
7D
-4.9%
1Y
-29.2%
Immuno-Biological Laboratories
Market Cap: JP¥8.8b
Engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide.
4570
JP¥942.00
7D
-5.8%
1Y
90.7%
WDB coco
Market Cap: JP¥6.2b
Provides contract and human resource services to pharmaceutical companies in Japan.
7079
JP¥2,580.00
7D
-1.1%
1Y
-11.0%